Skip to main navigation Skip to search Skip to main content

Are plasma markers for Alzheimer’s disease ready for clinical use?

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Plasma biomarkers pertaining to the underlying pathophysiology of Alzheimer’s disease have recently become available (for example, amyloid beta and phosphorylated tau).

Original languageEnglish (US)
Pages (from-to)94-96
Number of pages3
JournalNature Aging
Volume2
Issue number2
DOIs
StatePublished - Feb 2022

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Aging
  • Geriatrics and Gerontology

Fingerprint

Dive into the research topics of 'Are plasma markers for Alzheimer’s disease ready for clinical use?'. Together they form a unique fingerprint.

Cite this